直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Teva Pharmaceuticals International GmbH

Eli Lilly and Company

Represented Eli Lilly in multiple Federal Circuit appeals involving antibody patents.

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, 2020-1747, -1748, -1749, -1750, -1751, -1752, -1876, -1877, -1878, Fed. Cir.

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Erin M. Sommers, Ph.D.
Partner
Washington, DC
+1 202 408 4292
Email
Pier D. DeRoo
Partner
Washington, DC
+1 202 408 4418
Email
Charles T. Collins-Chase
Partner
Washington, DC
+1 202 408 4108
Email
Yieyie Yang, Ph.D.
Partner
Washington, DC
+1 202 216 5170
Email
Yoonjin Lee, Ph.D.
Partner
Washington, DC
+1 202 408 4332
Email

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals International

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Eli Lilly and Company

Eli Lilly and Co. wins challenge to patents covering its osteoporosis drug, Evista®

Eli Lilly and Company

When the patent for Zyprexa® and $2 billion in annual revenue were on the line, Eli Lilly turned to Finnegan

Eli Lilly and Company

Sun Pharmaceutical Inds. v. Eli Lilly and Co. 

Eli Lilly and Company

Eli Lilly and Company v. Actavis Labs. UT Inc.

Eli Lilly and Company

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP